Biomarkers in transplantation: Prospective, blinded measurement of predictive value for the flow cytometry crossmatch after negative antiglobulin crossmatch in kidney transplantation
- 1 October 2006
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 70 (8) , 1474-1481
- https://doi.org/10.1038/sj.ki.5001785
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Two Corticosteroid-Free Regimens—Tacrolimus Monotherapy after Basiliximab Administration and Tacrolimus/Mycophenolate Mofetil—in Comparison with a Standard Triple Regimen in Renal Transplantation: Results of the Atlas StudyTransplantation, 2005
- Diagnosis and treatment of antibody-mediated kidney allograft rejectionTransplant International, 2003
- Diagnosis and treatment of antibody-mediated kidney allograft rejectionTransplant International, 2003
- Characteristics of Good Causation StudiesSeminars in Reproductive Medicine, 2003
- Improved specificity and sensitivity when using pronase-digested lymphocytes to perform flow-cytometric crossmatch prior to renal transplantationTransplant International, 2002
- Cytomegalovirus seromismatching increases the risk of acute renal allograft rejection.Transplantation, 2002
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- The combined impact of donor age and acute rejection on long-term cadaver renal allograft survivalSurgery, 1999
- FLOW CYTOMETRY CROSS-MATCHTransplantation, 1997
- EVALUATION OF THE FLOW CYTOMETRIC CROSSMATCHTransplantation, 1996